Skip to end of metadata
Go to start of metadata

1a. Project Name

FHIR-Based Quality Reporting White Paper

1b. Project ID


1c. Is Your Project an Investigative Project (aka PSS-Lite)?


1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?


1e. Today's Date

1f. Name of standard being reaffirmed

1g. Project Artifact Information

1h. ISO/IEC Standard to Adopt

1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?

1j. Unit of Measure

2a. Primary/Sponsor WG

Clinical Quality Information

2b. Co-Sponsor WG


2c. Co-Sponsor Level of Involvement

Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)

2c. Co-Sponsor Update Periods


2d. Project Facilitator

Bryn Rhodes

2e. Other Interested Parties (and roles)

Angie Glotstein
Matthew Burton
Vocabulary Work Group

2f. Modeling Facilitator

2g. Publishing Facilitator

Bryn Rhodes

2h. Vocabulary Facilitator

Rob McClure

2i. Domain Expert Representative

Juliet Rubini (Mathematica), Ben Hamlin (NCQA), Paul Denning (MITRE), Jen Seeman (ESAC), Cynthia Barton (Cognitive), Yan Heras (ESAC), Scott Fradkin (Flexion), Carol Macumber (Apelon), Sam Sayer (MITRE)

2j. Business Requirements Analyst

2k. Conformance Facilitator

2l. Other Facilitators

2m. Implementers

3a. Project Scope

This project will assemble a white paper discussing the potential benefits of using a FHIR-based approach to clinical quality measurement and reporting.


3b. Project Need

Discussions about the use of FHIR in the quality measurement and reporting space often end up addressing many of the same concerns. This white paper will provide a single source of vetted guidance related to the use of FHIR for quality reporting.

3c. Security Risk


3d. External Drivers

3e. Objectives/Deliverables and Target Dates

Draft Available - January 2020
Ballot Informative - May 2020

3f. Common Names / Keywords / Aliases:

FHIR, Clinical Quality Reporting, Clinical Quality Measurement

3g. Lineage

3h. Project Dependencies

3i. HL7-Managed Project Document Repository URL:

3j. Backwards Compatibility


3k. Additional Backwards Compatibility Information (if applicable)

3l. Using Current V3 Data Types?


3l. Reason for not using current V3 data types?

3m. External Vocabularies


3n. List of Vocabularies

3o. Earliest prior release and/or version to which the compatibility applies

4a. Products

White Paper

4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?

4c. FHIR Profiles Version

4d. Please define your New Product Definition

4d. Please define your New Product Family

5a. Project Intent

White Paper

5a. White Paper Type

Balloted Informative

5a. Is the project adopting/endorsing an externally developed IG?

5a. Externally developed IG is to be (select one)

5a. Specify external organization

5a. Revising Current Standard Info

5b. Project Ballot Type


5c. Additional Ballot Info

5d. Joint Copyright


5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.


6a. External Project Collaboration

6b. Content Already Developed


6c. Content externally developed?


6d. List Developers of Externally Developed Content

6e. Is this a hosted (externally funded) project?


6f. Stakeholders

Quality Reporting Agencies, Regulatory Agency, Standards Development Organizations (SDOs), Payors

6f. Other Stakeholders

6g. Vendors

EHR, PHR, Health Care IT, Clinical Decision Support Systems

6g. Other Vendors

6h. Providers

Healthcare Institutions (hospitals, long term care, home care, mental health)

6h. Other Providers

6i. Realm


7d. US Realm Approval Date

7a. Management Group(s) to Review PSS


7b. Sponsoring WG Approval Date

Dec 13, 2019

7c. Co-Sponsor Approval Date

Feb 20, 2020

7c. Co-Sponsor 2 Approval Date

7c. Co-Sponsor 3 Approval Date

7c. Co-Sponsor 4 Approval Date

7c. Co-Sponsor 5 Approval Date

7c. Co-Sponsor 6 Approval Date

7c. Co-Sponsor 7 Approval Date

7c. Co-Sponsor 8 Approval Date

7c. Co-Sponsor 9 Approval Date

7c. Co-Sponsor 10 Approval Date

7e. CDA MG Approval Date

7f. FMG Approval Date

Feb 19, 2020

7g. V2 MG Approval Date

7h. Architecture Review Board Approval Date

7i. Steering Division Approval Date

Jan 23, 2020

7j. TSC Approval Date

Mar 02, 2020

1 Comment

  1. Added Sam Sayer (MITRE) to the list of domain expert representatives (2i)